CongressBuys

Congress trades in Regeneron Pharmaceuticals (REGN)

Healthcare · Biotechnology

14 members of Congress have disclosed 55 trades in Regeneron Pharmaceuticals (REGN) since 2014: 26 buys and 29 sales. The most recent was disclosed on Oct 9, 2026. 1 trade was made by members of a committee that oversees Regeneron Pharmaceuticals's industry.

Trades disclosed
55
Members trading
14
Buys / sells
26 / 29
Reported value
$111K–$965K

Committee overlaps

Trades by members of a committee that oversees Regeneron Pharmaceuticals's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded REGN

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.